NL7709092A - Werkwijze ter bereiding van cefalosporinever- bindingen met antibacteriele activiteit als- mede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten. - Google Patents
Werkwijze ter bereiding van cefalosporinever- bindingen met antibacteriele activiteit als- mede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten.Info
- Publication number
- NL7709092A NL7709092A NL7709092A NL7709092A NL7709092A NL 7709092 A NL7709092 A NL 7709092A NL 7709092 A NL7709092 A NL 7709092A NL 7709092 A NL7709092 A NL 7709092A NL 7709092 A NL7709092 A NL 7709092A
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- components
- active component
- pharmaceutical preparations
- antibacterial activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3430276A GB1556438A (en) | 1976-08-17 | 1976-08-17 | Cephalosporin derivatives and the preparation thereof |
GB4974876 | 1976-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7709092A true NL7709092A (nl) | 1978-02-21 |
Family
ID=26262231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7709092A NL7709092A (nl) | 1976-08-17 | 1977-08-17 | Werkwijze ter bereiding van cefalosporinever- bindingen met antibacteriele activiteit als- mede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten. |
Country Status (7)
Country | Link |
---|---|
US (2) | US4172198A (nl) |
JP (1) | JPS5323993A (nl) |
CH (1) | CH634848A5 (nl) |
DE (1) | DE2737066A1 (nl) |
ES (2) | ES461688A1 (nl) |
FR (1) | FR2362146A1 (nl) |
NL (1) | NL7709092A (nl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4343938A (en) * | 1978-03-24 | 1982-08-10 | American Cyanamid Company | 7-[Dα-(Coumarin-3-carboxamido)arylacetamido]-cephalosporanic acids or salts |
IT1141286B (it) * | 1980-04-17 | 1986-10-01 | Dob Far Spa | Esteri delle desacetossi cefalosporine loro sali e procedimenti per il loro ottenimento |
JPS5855491A (ja) * | 1981-09-29 | 1983-04-01 | Eisai Co Ltd | 3−カルバモイルオキシメチルセフエム誘導体およびその製造法 |
KR20020085180A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
KR20020085176A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
GB0116142D0 (en) * | 2001-07-02 | 2001-08-22 | Astrazeneca Ab | Method |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769281A (en) * | 1970-07-09 | 1973-10-30 | Lilly Co Eli | Deblocking process for cephalosporin antibiotics |
US3867380A (en) * | 1971-02-18 | 1975-02-18 | Smithkline Corp | 3-Heterocyclic thiomethylcephalosporins |
IL38099A (en) * | 1970-12-17 | 1976-01-30 | Smith Kline French Lab | 3-heterocyclyl thiomethylcephalosporins |
CH606016A5 (en) * | 1973-08-01 | 1978-10-13 | Ciba Geigy Ag | Antibacterial 3-pyridino-cephalosporin cpds. |
AR208171A1 (es) * | 1972-09-29 | 1976-12-09 | Ciba Geigy Ag | Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico |
JPS551273B2 (nl) * | 1972-12-21 | 1980-01-12 | ||
CA1022544A (en) * | 1972-12-21 | 1977-12-13 | Yukiyasu Murakami | Process of preparing a heterocyclic acyl group-substituted cephalosporin derivative |
JPS5143785A (en) * | 1974-10-11 | 1976-04-14 | Yamanouchi Pharma Co Ltd | Shinsefuarosuhorinkanrenkagobutsuno goseiho |
GB1479711A (en) * | 1973-06-12 | 1977-07-13 | Beecham Group Ltd | Acylureido cephalosporins |
US4058610A (en) * | 1973-09-13 | 1977-11-15 | Pfizer Inc. | 7-D-(α-Acylamino-arylacetamido)-cephalosporanic acid derivatives |
JPS4970990A (nl) * | 1973-09-29 | 1974-07-09 | ||
DE2407715C2 (de) * | 1974-02-18 | 1982-12-02 | Bayer Ag, 5090 Leverkusen | Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel |
US4107304A (en) * | 1974-02-18 | 1978-08-15 | Bayer Aktiengesellschaft | Oxo-imidazolidine substituted cephalosporins and antibacterial compositions and methods of combatting bacteria employing them |
DE2512284A1 (de) * | 1974-03-28 | 1975-10-09 | Fujisawa Pharmaceutical Co | Cephalosporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel |
US4068074A (en) * | 1974-04-05 | 1978-01-10 | Yamanouchi Pharmaceutical Co., Ltd. | Cephalosporin derivatives having at the 3-position of the cephem ring a heterocyclic thiomethyl group with a carboxy or sulfo group and at the 7-position of the cephem ring an α-heterocylic acylaminophenyl-acetamide group |
US4110327A (en) * | 1974-05-09 | 1978-08-29 | Toyama Chemical Co., Ltd. | 2,3 Diketo-piperazinocarbonylamino alkanoic acids and derivatives |
JPS5170788A (en) * | 1974-12-13 | 1976-06-18 | Toyama Chemical Co Ltd | Shinkina sefuarosuhorinruino seizoho |
US4154831A (en) * | 1974-05-13 | 1979-05-15 | Ciba-Geigy Corporation | Cephalosporins having an α-acylaminoacetic acid side chain |
CH606001A5 (nl) * | 1974-05-13 | 1978-10-13 | Ciba Geigy Ag | |
JPS50151895A (nl) * | 1974-05-31 | 1975-12-06 | ||
JPS50157387A (nl) * | 1974-06-06 | 1975-12-19 | ||
US3985740A (en) * | 1974-07-26 | 1976-10-12 | Bristol-Myers Company | 7-[D-(α-amino-α-phenyl-, 2-thienyl- and 3-thienylacetamido)]-3-(5-methylthiazol-2-yl)carbonylthiomethyl-3-cephem-4-carboxylic acids |
CA1074784A (en) * | 1974-09-06 | 1980-04-01 | Sumitomo Chemical Company | N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS |
JPS5132576A (en) * | 1974-09-06 | 1976-03-19 | Sumitomo Chemical Co | Nn ashiruamino arufua ariiruasetoamidosefuarosuhorinruinoseiho |
GB1498025A (en) * | 1975-10-01 | 1978-01-18 | Beecham Group Ltd | 3-carbamoyloxymethyl-7-8-(substituted acetamido)-3-cephem-4-carboxylic acid derivatives and methods for their preparation |
GB1469797A (en) * | 1974-11-07 | 1977-04-06 | Pfizer Ltd | Antibacterial cephalosporin derivatives |
US4053470A (en) * | 1974-12-23 | 1977-10-11 | Parke, Davis & Company | Substituted-1,2-dihydro-2-oxonicotinyl-cephalosporins |
US4224442A (en) * | 1975-03-03 | 1980-09-23 | Eli Lilly And Company | 7-Ureido acetamido substituted cephalosporin antibiotics |
JPS5293790A (en) * | 1976-02-02 | 1977-08-06 | Sumitomo Chem Co Ltd | 7-(n-acylamino-alpha-arylacetamide) cephalosporins |
US4061630A (en) * | 1976-02-20 | 1977-12-06 | Eli Lilly And Company | 7-Substituted-ureido-3-carbamoyloxymethyl cephalosporin antibiotics |
AU498968B2 (en) * | 1976-03-03 | 1979-03-29 | Sumitomo Chemical Company, Limited | Cephalosporins |
US4103008A (en) * | 1976-04-07 | 1978-07-25 | Ishimaru Toshiyasu | 7[2(2,3 Dioxopiperazin-1-yl-carbonylamino)substituted 2 phenylacetamido]-3-2'-thiadiazolyl cephalosporanic acid derivatives |
US4048161A (en) * | 1976-05-20 | 1977-09-13 | Eli Lilly And Company | 7-[α-(Benzimidazol-2-ylcarbonylamino)-arylacetamido]ephalosporins |
-
1977
- 1977-08-10 CH CH980477A patent/CH634848A5/de not_active IP Right Cessation
- 1977-08-10 FR FR7724611A patent/FR2362146A1/fr active Granted
- 1977-08-11 JP JP9685077A patent/JPS5323993A/ja active Granted
- 1977-08-15 US US05/824,910 patent/US4172198A/en not_active Expired - Lifetime
- 1977-08-17 ES ES461688A patent/ES461688A1/es not_active Expired
- 1977-08-17 DE DE19772737066 patent/DE2737066A1/de not_active Withdrawn
- 1977-08-17 NL NL7709092A patent/NL7709092A/nl not_active Application Discontinuation
-
1978
- 1978-07-31 ES ES472240A patent/ES472240A1/es not_active Expired
-
1979
- 1979-06-04 US US06/045,011 patent/US4324892A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS6337794B2 (nl) | 1988-07-27 |
FR2362146B1 (nl) | 1982-10-15 |
ES472240A1 (es) | 1979-10-16 |
CH634848A5 (de) | 1983-02-28 |
JPS5323993A (en) | 1978-03-06 |
US4324892A (en) | 1982-04-13 |
US4172198A (en) | 1979-10-23 |
DE2737066A1 (de) | 1978-02-23 |
FR2362146A1 (fr) | 1978-03-17 |
ES461688A1 (es) | 1978-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7714329A (nl) | Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7708741A (nl) | Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. | |
BE826260A (nl) | Werkwijze voor het bereiden van werkzame cyclohexanolderivaten en van preparaten, die deze bevatten | |
NL7803195A (nl) | Heterocyclische verbindingen met farmaceutische activiteit, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten, die deze verbindingen als actieve component bevatten. | |
NL7709697A (nl) | Werkwijze ter bereiding van thiazolidinederivaten, alsmede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten. | |
NL7603193A (nl) | Werkwijze ter bereiding van acyclische, alicycli- sche en aromatische n-gesubstitueerde halogeen-2- -pyrrolidinonen met herbicidewerking alsmede her- bicidepreparaten die deze verbindingen als actie- ve component bevatten. | |
NL7706064A (nl) | Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten. | |
NL7700379A (nl) | Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7614538A (nl) | Werkwijze ter bereiding van farmacologisch actieve heterocyclische verbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
NL7713470A (nl) | Werkwijze ter bereiding van 2-gesubstitueerde benzimidazoolverbindingen en de zuuradditiezou- ten daarvan alsmede farmaceutische preparaten die deze verbindingen als actieve component be- vatten. | |
BE857181A (nl) | Werkwijze ter bereiding van n-alkynyl-&-(gesugstitueerde fenoxy) alkylamiden met herbicidewerking alsmede herbicide-preparaten die deze verbindingen als actieve component bevatten | |
NL7604797A (nl) | Werkwijze ter bereiding van nieuwe antibacteriele middelen alsmede preparaten die deze verbindingen als actieve component bevatten. | |
NL7610480A (nl) | Werkwijze ter bereiding van hypolipemische ver- bindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7607337A (nl) | Werkwijze ter bereiding van spirocycloalkyl- prostaanzuren en derivaten daarvan, alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten. | |
NL7609559A (nl) | Werkwijze ter bereiding van oxazolidinonen alsmede geneeskrachtige middelen die deze ver- bindingen als actieve component bevatten. | |
NL7702180A (nl) | Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7711414A (nl) | Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7707150A (nl) | Werkwijze ter bereiding van 2-lagere alkyl-7-ge- substitueerde-2 of 3-cefem-4-carbonzuurverbin- dingen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7709092A (nl) | Werkwijze ter bereiding van cefalosporinever- bindingen met antibacteriele activiteit als- mede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten. | |
NL155827B (nl) | Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten. | |
NL7515085A (nl) | Werkwijze ter bereiding van cefalosporinederiva- ten als antimicrobiele preparaten die deze deri- vaten als actieve componenten bevatten. | |
NL7807890A (nl) | Pyranochromoonderivaten, alsmede preparaten voor de be- handeling van allergische aandoeningen, die deze ver- bindingen bevatten. | |
NL7714063A (nl) | Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten. | |
NL7505961A (nl) | Werkwijze ter bereiding van een antibacterieel middel, alsmede preparaten die dit middel als actieve component bevatten. | |
NL7707751A (nl) | Werkwijze ter bereiding van cefalosporineverbin- dingen alsmede antibacteriele preparaten die deze componenten bevatten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BV | The patent application has lapsed |